Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.4850
+0.0140 (2.97%)
At close: Jan 9, 2026
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $521.08 million as of January 9, 2026. Its market cap has decreased by -11.31% in one year.
Market Cap
521.08M
Enterprise Value
500.76M
Revenue
122.89M
Ranking
n/a
PE Ratio
37.25
Stock Price
$0.49
Market Cap Chart
Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 521.08M, an increase of 5,341.98%. That is a compound annual growth rate of 15.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 521.08M | -1.07% |
| Dec 31, 2025 | 526.74M | -8.88% |
| Dec 31, 2024 | 578.04M | 306.60% |
| Dec 29, 2023 | 142.16M | 374.74% |
| Dec 30, 2022 | 29.95M | -10.40% |
| Dec 31, 2021 | 33.42M | -36.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 790.31M |
| Glass House Brands | 711.87M |
| Northwest Biotherapeutics | 409.64M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 386.18M |
| CytoDyn | 343.01M |
| Silence Therapeutics | 260.73M |
| OpGen | 180.66M |